MET and lung cancer: demonstrated that ARQ 197 has broad-spectrum antineoplastic effects, including lung cancer, melanoma, breast cancer, colon cancer, ovarian cancer, and gastric cancer, by inhibiting the downstream c-Met effectors and in turn exhibiting the antiproliferative and proapoptotic effects.